🇺🇸 FDA
Pipeline program

GC4711 30mg

GTI-4711-002

Phase 1 small_molecule completed

Quick answer

GC4711 30mg for Healthy is a Phase 1 program (small_molecule) at Galera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Galera Therapeutics
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials